Shushan Sang

Shushan Sang

Auto-generated profile, based on publicly available information

Shushan Sang

Department of Otolaryngology, Xiangya Hospital, Central South University, Changsha, China

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2019 in Frontiers in Genetics
Verified
Journal Article
Open access
SSShushan Sang
Shushan Sang
JLJie Ling
Jie Ling
XLXuezhong Liu
Xuezhong Liu
LMLingyun Mei
Lingyun Mei
Xinzhang CaiXinzhang Cai
Xinzhang Cai
YFYong Feng
Yong Feng
Autosomal recessive non-syndromic hearing loss (ARNSHL) is a highly heterogeneous disease involving more than 70 pathogenic genes. However, most ARNSHL families have small-sized pedigrees with limited genetic information, rendering challenges for the molecular diagnosis of these patients. Therefore, we attempted to establish a strategy for identifying deleterious variants associated with ARNSHL by applying proband whole-exome sequencing (proband-WES). Aside from desiring to improve molecular diagnostic rates, we also aimed to search for novel deafness genes shared by patients with similar phenotype, making up for the deficiency of small ARNSHL families. In this study, 48.5% (16/33) families were detected the pathogenic variants in eight known deafness genes, including 10 novel variants identified in TMPRSS3 (MIM 605551), MYO15A (MIM 602666), TMC1 (MIM 606706), ADGRV1 (MIM 602851), and PTPRQ (MIM 603317). Apart from six novel variants with a truncating effect (nonsense, deletion, insertion, and splice-site), four novel missense variants were not found in 200 unrelated control population by using Sanger sequencing. It is important to note that none of novel genes were shared across different pedigrees, indicating that a larger sample size might be needed. Proband-WES is a cost-effective and precise way of identifying causative variants in nuclear families with ARNSHL. This economical strategy may be appropriated as a clinical application to provide molecular diagnostics, genetic counseling, and individualized health maintenance measures for patients with ARNSHL at hearing clinics.

1 November 2018 in World Neurosurgery
Verified
Journal Article
Closed access
SSShushan Sang
Shushan Sang
SWSiyi Wanggou
Siyi Wanggou
ZWZaibin Wang
Zaibin Wang
XLXuelei Lin
Xuelei Lin
NJNian Jiang
Nian Jiang
XLXuejun Li
Xuejun Li

1 December 2018 in International Journal of Pediatric Otorhinolaryngology
Verified
Journal Article
Closed access
YDYuyuan Deng
Yuyuan Deng
SSShushan Sang
Shushan Sang
JWJie Wen
Jie Wen
YLYalan Liu
Yalan Liu
JLJie Ling
Jie Ling
YFYong Feng
Yong Feng